Janahita Biotech Research And Training(Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 26-12-2024
- Paid Up Capital ₹ 0.50 M
as on 26-12-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -99.80%
(FY 2019)
- Profit -64.21%
(FY 2019)
- Ebitda -61.34%
(FY 2019)
- Net Worth -151.21%
(FY 2019)
- Total Assets 6.99%
(FY 2019)
About Janahita Biotech Research And Training(Opc)
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Parayitam Ratnam serves as a director at the Company.
- CIN/LLPIN
U74900TG2014OPC095286
- Company No.
095286
- Incorporation Date
14 Aug 2014
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Janahita Biotech Research And Training Private Limited (Opc) offer?
Janahita Biotech Research And Training Private Limited (Opc) offers a wide range of products and services, including Laboratory Reagents.
Who are the key members and board of directors at Janahita Biotech Research And Training(Opc)?
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parayitam Ratnam  | Director | 14-Aug-2014 | Current |
Financial Performance of Janahita Biotech Research And Training(Opc).
Janahita Biotech Research And Training Private Limited (Opc), for the financial year ended 2019, experienced significant reduction in revenue, with a 99.8% decrease. The company also saw a substantial fall in profitability, with a 64.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 151.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Janahita Biotech Research And Training(Opc)?
Unlock access to Janahita Biotech Research And Training(Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Janahita Biotech Research And Training(Opc)?
Unlock and access historical data on people associated with Janahita Biotech Research And Training(Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Janahita Biotech Research And Training(Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Janahita Biotech Research And Training(Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
